Search research articles
Contact Us
Filters
Showing results (811-820 of 837) with videos related to
Page
of 84
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 16, 2024
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints
Sailish Honap, Vipul Jairath, Bruce E Sands, et al.
Lancet (London, England)
|
June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Silvio Danese, Séverine Vermeire, Wen Zhou, et al.
Gastroenterology
|
April 12, 2022
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery
Benjamin L Cohen, Phillip Fleshner, Sunanda V Kane, et al.
The American Journal of Gastroenterology
|
January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases
Michael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Alimentary Pharmacology & Therapeutics
|
November 10, 2015
Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation
A J F Coimbra, J Rimola, S O'Byrne, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease
Arthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology
|
January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience
Jeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Inflammatory Bowel Diseases
|
July 13, 2022
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
B J Monk, M F Brady, C Aghajanian, et al.
American Journal of Medical Genetics
|
September 6, 1996
Toward quality assurance for metaphase FISH: a multi-center experience
G Dewald, R Stallard, P I Bader, et al.
Page
of 84
Search research articles
Search
Showing results (811-820 of 837) with videos related to
Sort By:
Page
of 84
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 16, 2024
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints
Sailish Honap, Vipul Jairath, Bruce E Sands, et al.
Lancet (London, England)
|
June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Silvio Danese, Séverine Vermeire, Wen Zhou, et al.
Gastroenterology
|
April 12, 2022
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery
Benjamin L Cohen, Phillip Fleshner, Sunanda V Kane, et al.
The American Journal of Gastroenterology
|
January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases
Michael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Alimentary Pharmacology & Therapeutics
|
November 10, 2015
Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation
A J F Coimbra, J Rimola, S O'Byrne, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease
Arthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology
|
January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience
Jeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Inflammatory Bowel Diseases
|
July 13, 2022
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
B J Monk, M F Brady, C Aghajanian, et al.
American Journal of Medical Genetics
|
September 6, 1996
Toward quality assurance for metaphase FISH: a multi-center experience
G Dewald, R Stallard, P I Bader, et al.
Page
of 84